YNL184C Antibody

What is YNL184C protein and why is an antibody against it valuable for research?

YNL184C is an uncharacterized protein identified in Saccharomyces cerevisiae (Baker's yeast) that currently lacks detailed functional characterization. The antibody targeting this protein serves as a specialized tool for yeast molecular biology research, enabling the investigation of this protein's localization, expression patterns, and potential functions. Despite the limited knowledge about YNL184C's biological role, antibodies against such uncharacterized proteins play a crucial role in exploratory research to elucidate novel cellular mechanisms in yeast systems.

For researchers working on yeast biology, this antibody provides a means to detect and track YNL184C in various experimental contexts, potentially revealing its involvement in cellular processes. The antibody is particularly valuable for studies focused on comprehensive yeast proteomics and functional genomics projects that aim to annotate previously uncharacterized open reading frames.

What are the technical specifications of commercially available YNL184C antibodies?

The commercially available YNL184C antibody is typically a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae YNL184C protein from strain ATCC 204508 / S288c (Baker's yeast) . According to product specifications, it possesses the following characteristics:

These technical specifications ensure researchers can appropriately integrate the antibody into their experimental design while understanding its physical and chemical properties .

What validated applications are appropriate for YNL184C antibody?

YNL184C antibody has been validated primarily for enzyme-linked immunosorbent assay (ELISA) and Western blotting (WB) applications . While these represent the manufacturer-validated applications, researchers have explored additional uses in yeast research, including:

• Western Blotting: The primary application for detecting YNL184C protein in yeast cell lysates, providing information about protein expression levels and molecular weight confirmation. This technique is particularly useful for detecting the presence of YNL184C in different yeast strains or under various experimental conditions.

• ELISA: Enables quantitative detection of YNL184C in complex samples, offering higher throughput than Western blotting for quantitative analysis.

• Protein Localization Studies: Although not explicitly validated by manufacturers, researchers have adapted the antibody for immunofluorescence microscopy to map the subcellular localization of YNL184C within yeast cells.

• Immunoprecipitation: Potentially useful for isolating YNL184C and its binding partners, though each researcher should validate this application independently.

When adapting the antibody for non-validated applications, thorough controls should be implemented, including using YNL184C deletion strains as negative controls to confirm specificity.

How can researchers optimize Western blot protocols specifically for YNL184C detection?

Optimizing Western blot protocols for YNL184C detection requires addressing several yeast-specific challenges. First, yeast cell walls necessitate efficient lysis methods. Researchers should consider the following protocol modifications:

• Cell Lysis Optimization: Use glass bead disruption with protease inhibitors in a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, and 1 mM EDTA. This combination helps maintain protein integrity while efficiently disrupting the tough yeast cell wall.

• Protein Loading and Transfer Parameters:

  • Total protein loading: 20-30 μg per lane

  • Gel percentage: 10-12% SDS-PAGE

  • Transfer conditions: 100V for 1 hour in standard Towbin buffer

• Blocking and Antibody Dilutions:

  • Blocking: 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Primary antibody (YNL184C): 1:1000 dilution, overnight at 4°C

  • Secondary antibody (anti-rabbit HRP): 1:5000 dilution, 1 hour at room temperature

• Detection Sensitivity Enhancement:

  • Use enhanced chemiluminescence (ECL) substrates optimized for low-abundance proteins

  • Consider longer exposure times (up to 5 minutes) as YNL184C may be expressed at low levels

• Critical Controls:

  • YNL184C deletion strain lysate as negative control

  • YNL184C overexpression strain as positive control

  • Loading control (e.g., anti-Pgk1) to normalize expression levels

These optimizations help overcome the typical challenges in detecting uncharacterized yeast proteins while maintaining specificity and sensitivity .

What cross-reactivity concerns exist with YNL184C antibody?

Cross-reactivity is a significant concern when working with antibodies against yeast proteins due to conserved domains and structural similarities across the proteome. For YNL184C antibody, consider the following:

How can researchers verify the specificity of YNL184C antibody in their experimental system?

Verifying antibody specificity is crucial for generating reliable data, especially when working with uncharacterized proteins like YNL184C. Researchers should implement a multi-faceted validation approach:

• Genetic Validation:

  • Test the antibody against lysates from wild-type and YNL184C deletion strains

  • The antibody should detect a band of the expected molecular weight in wild-type samples that is absent in deletion strains

• Overexpression Validation:

  • Generate a strain overexpressing tagged YNL184C (e.g., with HA or FLAG tag)

  • Perform parallel detection with both YNL184C antibody and anti-tag antibody

  • Confirm co-localization of signals in Western blot and immunofluorescence applications

• Peptide Competition Assays:

  • Pre-incubate the antibody with excess immunizing peptide

  • This should abolish specific signals while leaving non-specific signals intact

• Mass Spectrometry Validation:

  • Perform immunoprecipitation with the YNL184C antibody

  • Analyze precipitated proteins by mass spectrometry

  • Confirm presence of YNL184C in the precipitated fraction

• Correlation with mRNA Expression:

  • Compare protein detection patterns with YNL184C mRNA expression data

  • Conditions that alter mRNA levels should show corresponding changes in protein detection

This comprehensive validation approach ensures that experimental observations can be confidently attributed to YNL184C rather than to cross-reactive signals or artifacts .

How can YNL184C antibody be incorporated into studies investigating yeast stress response pathways?

Incorporating YNL184C antibody into stress response studies can provide insights into potential functional roles of this uncharacterized protein. A systematic approach includes:

• Expression Analysis Under Varied Stress Conditions:

  • Subject yeast cultures to different stressors (oxidative, heat shock, nutrient deprivation, DNA damage)

  • Harvest cells at multiple time points (0, 15, 30, 60, 120 minutes)

  • Perform Western blot analysis using YNL184C antibody to track expression changes

  • Correlate protein levels with transcriptomic data from stress-response experiments

• Subcellular Relocalization Studies:

  • Use immunofluorescence with YNL184C antibody to track potential stress-induced relocalization

  • Compare localization patterns before and after stress induction

  • Co-stain with markers for subcellular compartments (nucleus, ER, Golgi, mitochondria)

• Protein Interaction Network Analysis:

  • Perform co-immunoprecipitation with YNL184C antibody under normal and stress conditions

  • Identify stress-specific interaction partners using mass spectrometry

  • Construct interaction networks to place YNL184C in relevant cellular pathways

• Correlation with Known Stress Response Factors:
  Similar to methodologies used in studying alpha-synuclein toxicity in yeast, researchers can examine if YNL184C interacts with known stress response factors by comparing expression patterns and localization .

This multi-faceted approach can reveal whether YNL184C participates in specific stress response pathways and provides a foundation for functional characterization of this uncharacterized protein.

What methodological approaches can integrate YNL184C antibody with genomic screening data?

Integrating antibody-based protein detection with genomic screening requires sophisticated methodological approaches. Researchers can implement the following strategies:

• Correlation of Genetic Interaction Data with Protein Expression:

  • Perform synthetic genetic array (SGA) analysis with YNL184C deletion strain

  • Use YNL184C antibody to assess protein expression in genetic interactors

  • Identify genes whose deletion alters YNL184C expression or localization

• Chromatin Immunoprecipitation (ChIP) Studies:

  • If YNL184C is found to have nuclear localization, perform ChIP with YNL184C antibody

  • Sequence precipitated DNA to identify potential binding sites

  • Correlate with transcriptomic data to identify genes potentially regulated by YNL184C

• Integration with High-Throughput Phenotypic Data:

  • Use antibody detection of YNL184C across strains with variable phenotypes

  • Correlate expression levels with phenotypic strength

  • Apply machine learning algorithms to identify associations between YNL184C expression patterns and specific cellular phenotypes

• Functional Validation of Genomic Hits:
  Similar to approaches used in BRCA1 functional genomics studies, researchers can validate genomic screen hits by examining their impact on YNL184C expression, modification, or localization using the antibody .

This integrative approach bridges the gap between genetic and proteomic studies, providing a more comprehensive understanding of YNL184C's potential functions in cellular processes.

How can post-translational modifications of YNL184C be investigated using available antibodies?

Investigating post-translational modifications (PTMs) of YNL184C requires specialized approaches beyond standard antibody applications:

• Identification of Potential Modification Sites:

  • Perform in silico analysis of YNL184C sequence for PTM motifs

  • Focus on common yeast PTMs: phosphorylation, ubiquitination, SUMOylation, acetylation

• Modification-Specific Detection Methods:

  • Phosphorylation detection:

    • Use Phos-tag gels with YNL184C antibody to detect mobility shifts

    • Treat samples with phosphatase before Western blotting to confirm phosphorylation

    • Compare migration patterns under different growth conditions

  • Ubiquitination detection:

    • Perform immunoprecipitation with YNL184C antibody followed by ubiquitin Western blot

    • Use proteasome inhibitors to enhance detection of ubiquitinated forms

• Mass Spectrometry Approach:

  • Immunoprecipitate YNL184C using the antibody

  • Perform tryptic digestion of isolated protein

  • Analyze by LC-MS/MS with specific focus on modified peptides

  • Compare modification patterns under different environmental conditions

• Targeted Mutational Analysis:

  • Create point mutations at predicted modification sites

  • Compare antibody detection patterns between wild-type and mutant proteins

  • Assess functional consequences of preventing specific modifications

This approach parallels methods used to study phosphorylation of alpha-synuclein in yeast models, where researchers confirmed modification by comparing wild-type and S129A mutant proteins using phospho-specific antibodies .

What experimental design would best integrate YNL184C antibody into studies of yeast protein-protein interaction networks?

To effectively integrate YNL184C antibody into protein-protein interaction studies, researchers should implement a comprehensive experimental design:

• Co-Immunoprecipitation Strategy:

  • Perform immunoprecipitation with YNL184C antibody under various conditions

  • Identify co-precipitating proteins by mass spectrometry

  • Validate key interactions using reciprocal co-IP with antibodies against identified partners

  • Compare interaction profiles under different environmental conditions

  Protocol highlights:

  • Use gentle lysis conditions (100 mM NaCl, 0.1% NP-40) to preserve weak interactions

  • Include DSP crosslinking step for capturing transient interactions

  • Implement stringent washing controls to eliminate non-specific binders

• Proximity-Based Labeling Approaches:

  • Create fusion proteins combining YNL184C with BioID or APEX2 enzymes

  • Use YNL184C antibody to confirm expression and localization of fusion proteins

  • Identify proximal proteins through streptavidin pulldown and mass spectrometry

  • Compare data with traditional co-IP results to build confidence in the interaction network

• Integration with Existing Interaction Databases:

  • Compare experimentally identified interactions with predictions from databases

  • Look for enrichment of specific cellular processes among interacting partners

  • Use computational approaches to place YNL184C in existing interaction networks

• Functional Validation of Interactions:

  • Perform genetic interaction studies between YNL184C and genes encoding interacting proteins

  • Use YNL184C antibody to assess how deletion of interaction partners affects YNL184C expression, stability, or localization

  • Develop functional assays based on phenotypes associated with YNL184C deletion

This comprehensive approach parallels methods used in studies of BRCA1 interaction networks in yeast, where physical interactions were identified through co-immunoprecipitation and validated through functional studies .

How should researchers address inconsistent results when using YNL184C antibody?

When encountering inconsistent results with YNL184C antibody, researchers should implement a systematic troubleshooting approach:

• Antibody Quality Assessment:

  • Check antibody age, storage conditions, and freeze-thaw history

  • Perform dot blot analysis with purified antigen to assess antibody activity

  • Consider testing a new lot of antibody to rule out lot-to-lot variability

• Sample Preparation Optimization:

  • Evaluate different lysis methods (mechanical disruption, enzymatic lysis)

  • Test multiple buffer compositions varying salt concentration and detergent type

  • Include additional protease inhibitors to prevent degradation

  • Verify protein extraction efficiency using control antibodies against abundant yeast proteins

• Protocol Modification Matrix:

  • Systematically vary key parameters in a matrix format:

  Parameter	Variation 1	Variation 2	Variation 3
  Blocking agent	5% milk	3% BSA	Commercial blocker
  Primary antibody dilution	1:500	1:1000	1:2000
  Incubation time	1 hour RT	4 hours RT	Overnight 4°C
  Detection method	HRP/ECL	Fluorescent	Enhanced sensitivity ECL

• Biological Variability Assessment:

  • Test antibody performance across different yeast strains

  • Evaluate impact of growth phase and media composition

  • Consider whether YNL184C expression might be condition-dependent

• External Validation:

  • Create epitope-tagged YNL184C construct

  • Compare detection patterns between YNL184C antibody and anti-tag antibody

  • If discrepancies persist, prioritize results from tagged constructs for reliability

This methodical approach helps distinguish between technical issues with the antibody and genuine biological variability in YNL184C expression or modification .